why choose us

First received: January 04, 2025

Clinical Trial: ROTEM-based Optimization of Anticoagulation Regimens in Lung Transplantation

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Anticoagulation

Study Type: OBSERVATIONAL


Official Title: ROTEM-based Optimization of Anticoagulation Regimens in Lung Transplantation

Brief Summary: Extracorporeal membrane oxygenation (ECMO) is now a standard component of intraoperative support during lung transplantation, requiring anticoagulation management, typically with unfractionated heparin (UFH).While monitoring methods such as Activated Partial Thromboplastin Time (aPTT), Activated Partial Thromboplastin Time Ratio (aPTTr), Anti-Factor Xa Activity (anti-Xa), and Activated Clotting Time (ACT) are commonly used, a reliable bedside method remains elusive due to the unreliability of ACT at low UFH…

Read more